T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment
作者
Saskia J. Santegoets,Anita G.M. Stam,Sinéad M. Lougheed,Helen Gall,Petra E.T. Scholten,Martine Reijm,Karin Jooss,Natalie Sacks,Kristen Hege,Israel Lowy,Jean-Marie Cuillerot,B. Mary E. von Blomberg,Rik J. Scheper,Alfons J.M. van den Eertwegh,Winald R. Gerritsen,Tanja D. de Gruijl